Ads by Google

Prescription Drugs

FDA Delays Approval Of Genzyme's Synvisc-One

Genzyme Corp. has received a letter from FDA requesting additional analyses and data regarding the marketing application for Synvisc-One in the United States. The company now expects that approval of the next-generation Synvisc (hylan G-F 20) to be delayed in the U.S. until at least the second half of 2008.

Health and Wellness: 

Pages